chemotherapy: be given in cycles

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents treatment
Weight: 0.64
, regimen
Weight: 0.62
, modality
Weight: 0.61
, agent
Weight: 0.60
, prostate cancer
Weight: 0.59
Siblings gene therapy
Weight: 0.66
, breast cancer
Weight: 0.36
, dialysis
Weight: 0.36
, transplant
Weight: 0.34
, mastectomy
Weight: 0.34

Related properties

Property Similarity
be given in cycles 1.00
be administered in cycles 0.88
is given 0.77
be given in form 0.75

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.05
Rule weight: 0.13
Evidence weight: 0.49
Similarity weight: 0.77
Evidence: 0.60
¬ Remarkable(chemotherapy, be given in cycles) ⋁
Evidence: 0.86
¬ Remarkable(dialysis, is given)

Remarkability from sibling implausibility

0.44
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 0.77
Evidence: 0.25
Plausible(chemotherapy, be given in cycles) ⋁
Evidence: 0.86
Remarkable(dialysis, is given) ⋁
Evidence: 0.44
¬ Plausible(dialysis, is given)

Salient implies Plausible

0.22
Rule weight: 0.28
Evidence weight: 0.77
Similarity weight: 1.00
Evidence: 0.25
Plausible(chemotherapy, be given in cycles) ⋁
Evidence: 0.31
¬ Salient(chemotherapy, be given in cycles)

Similarity expansion

0.67
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.88
Evidence: 0.25
Plausible(chemotherapy, be given in cycles) ⋁
Evidence: 0.14
¬ Plausible(chemotherapy, be administered in cycles)
0.65
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.88
Evidence: 0.60
Remarkable(chemotherapy, be given in cycles) ⋁
Evidence: 0.34
¬ Remarkable(chemotherapy, be administered in cycles)
0.65
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.88
Evidence: 0.31
Salient(chemotherapy, be given in cycles) ⋁
Evidence: 0.20
¬ Salient(chemotherapy, be administered in cycles)
0.63
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.88
Evidence: 0.22
Typical(chemotherapy, be given in cycles) ⋁
Evidence: 0.20
¬ Typical(chemotherapy, be administered in cycles)
0.62
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.77
Evidence: 0.22
Typical(chemotherapy, be given in cycles) ⋁
Evidence: 0.07
¬ Typical(chemotherapy, is given)
0.52
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.75
Evidence: 0.22
Typical(chemotherapy, be given in cycles) ⋁
Evidence: 0.23
¬ Typical(chemotherapy, be given in form)
0.52
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.77
Evidence: 0.25
Plausible(chemotherapy, be given in cycles) ⋁
Evidence: 0.29
¬ Plausible(chemotherapy, is given)
0.44
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.75
Evidence: 0.25
Plausible(chemotherapy, be given in cycles) ⋁
Evidence: 0.41
¬ Plausible(chemotherapy, be given in form)
0.41
Rule weight: 0.85
Evidence weight: 0.63
Similarity weight: 0.77
Evidence: 0.31
Salient(chemotherapy, be given in cycles) ⋁
Evidence: 0.54
¬ Salient(chemotherapy, is given)
0.41
Rule weight: 0.85
Evidence weight: 0.64
Similarity weight: 0.75
Evidence: 0.60
Remarkable(chemotherapy, be given in cycles) ⋁
Evidence: 0.90
¬ Remarkable(chemotherapy, be given in form)
0.41
Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.77
Evidence: 0.60
Remarkable(chemotherapy, be given in cycles) ⋁
Evidence: 0.95
¬ Remarkable(chemotherapy, is given)
0.36
Rule weight: 0.85
Evidence weight: 0.56
Similarity weight: 0.75
Evidence: 0.31
Salient(chemotherapy, be given in cycles) ⋁
Evidence: 0.64
¬ Salient(chemotherapy, be given in form)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.91
Similarity weight: 1.00
Evidence: 0.31
Salient(chemotherapy, be given in cycles) ⋁
Evidence: 0.22
¬ Typical(chemotherapy, be given in cycles) ⋁
Evidence: 0.60
¬ Remarkable(chemotherapy, be given in cycles)

Typical implies Plausible

0.40
Rule weight: 0.48
Evidence weight: 0.84
Similarity weight: 1.00
Evidence: 0.25
Plausible(chemotherapy, be given in cycles) ⋁
Evidence: 0.22
¬ Typical(chemotherapy, be given in cycles)

Typicality and Rermarkability incompatibility between siblings

0.09
Rule weight: 0.14
Evidence weight: 0.83
Similarity weight: 0.77
Evidence: 0.60
¬ Remarkable(chemotherapy, be given in cycles) ⋁
Evidence: 0.29
¬ Typical(dialysis, is given)